A detailed history of Redpoint Investment Management Pty LTD transactions in Novo Cure LTD stock. As of the latest transaction made, Redpoint Investment Management Pty LTD holds 2,927 shares of NVCR stock, worth $45,749. This represents 0.03% of its overall portfolio holdings.

Number of Shares
2,927
Holding current value
$45,749
% of portfolio
0.03%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Oct 14, 2022

BUY
$67.99 - $89.57 $199,006 - $262,171
2,927 New
2,927 $222,000
Q4 2021

Jan 19, 2022

SELL
$75.08 - $121.99 $159,695 - $259,472
-2,127 Closed
0 $0
Q2 2021

Aug 05, 2021

BUY
$130.4 - $225.58 $68,720 - $118,880
527 Added 32.94%
2,127 $472,000
Q4 2020

Jan 13, 2021

BUY
$112.16 - $174.14 $179,456 - $278,624
1,600 New
1,600 $277,000

Others Institutions Holding NVCR

About NovoCure Ltd


  • Ticker NVCR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 104,950,000
  • Market Cap $1.64B
  • Description
  • NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...
More about NVCR
Track This Portfolio

Track Redpoint Investment Management Pty LTD Portfolio

Follow Redpoint Investment Management Pty LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Redpoint Investment Management Pty LTD, based on Form 13F filings with the SEC.

News

Stay updated on Redpoint Investment Management Pty LTD with notifications on news.